Graves' Disease · Currently recruiting
GenSci098 (YB-101)
Investigational biologic for the treatment of Graves' disease, evaluating disease control and safety as an alternative to current standard therapy.
Study details
Condition: Graves' Disease
Status: Recruiting
Registry: NCT07286656 on ClinicalTrials.gov
Site: EndoTrials Clinical Research Center, La Mesa, California
Full eligibility criteria are set by the study protocol and listed in the registry entry above. Our research team will review them with you, explain what participation involves, including visits, procedures and compensation where applicable, and answer your questions before you decide. Participation is voluntary, and you can withdraw at any time.
EndoTrials is the clinical research center of Diabetes & Endocrine Specialists, led by Darius A. Schneider, MD, PhD.